Pathios nabs $8.8 mln Series A
UK-based Pathios, a biotech company focused on treating autoimmune diseases and cancer, has raised $8.8 million in Series A financing.
UK-based Pathios, a biotech company focused on treating autoimmune diseases and cancer, has raised $8.8 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination